Hepatitis B Vaccination in Psychiatric patients in Morocco

Hepatitis B Virus Vaccination in Hemodialysis Patients: A Necessity for Individualizing of Immunization?

Immunity to Hepatitis B Vaccine in Thalassaemic Patients based on the Time Passed from Vaccination

Background & Aims: Hepatitis B virus is one of the causes of acute and chronic hepatitis. Due to multiple hospitalization and blood transfusion, thalassaemic patients are at higher risk of this infection. Duration of the immunity after vaccination in this high-risk group and the need for booster vaccination is uncertain. The aim of this study was to find antibody titration and immunity to Hepat...

Immune Response to Standard Hepatitis B Vaccination in HIV-Infected Patients

Background: Due to their similar routes of transmission, human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infection occurs considerably. HBV infection progresses more rapidly in HIV-infected patients. Therefore, HBV vaccination of all non-immune HIV infected patients is recommended. On the other hand, HIV-infected subjects have suboptimal responses to HBV vaccine. In this study...

Occult Hepatitis B in Patients Undergoing Chemotherapy

Introduction: The hepatitis B virus (HBV) is one health problem in Iran. Occult hepatitis B (OBI) is diagnosed by the detection of HBV DNA in the serum or liver tissue of patients for whom other serology, especially HBsAg and HBcAg, are negative. The current study aimed to determine the prevalence of OBI in patients who refer for chemotherapy. Methods: Al...

Hepatitis B & C epidemiology in Morocco

Hepatitis B (HBV) and C (HCV) viruses are major public health problems worldwide and are a serious cause of liver disease that may silently progress toward cirrhosis and hepatocellular carcinoma. The epidemiology of HBV and HCV infection in Morocco was studied. A large screening of HBsAg and HCVab was performed by third generation ELISA. Hepatitis B and C are parenterally transmitted with respe...